Etravirine

Back to search

Molecule Structure

Scientific Name

Etravirine

Description of the Drug

Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06414

Brand Name(s)

Intelence

Company Owner(s)

Carnegie Pharmaceuticals Llc, Janssen Research And Development Llc, Amneal Eu Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247

Unichem Links

SureChEMBL SCHEMBL52691
PharmGKB PA166014703
DrugBank DB06414
PubChem: Thomson Pharma 14856802
PubChem 193962
LINCS LSM-45824
Nikkaji J1.588.786I
PDBe 65B
BindingDB 50103642
EPA CompTox Dashboard DTXSID30181412
DrugCentral 1115
Brenda 6272 135069 9938
ChemicalBook CB51509336 CB11455806
rxnorm ETRAVIRINE INTELENCE
PubChem: Drugs of the Future 12015430
ChEBI 63589
ZINC ZINC000000602632